This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Jin Hyub Paik: Innovator in Pharmaceutical Composition
Introduction
Jin Hyub Paik is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of inflammatory diseases and asthma. His innovative work has led to the development of a unique pharmaceutical composition that utilizes natural extracts.
Latest Patents
Jin Hyub Paik holds 1 patent for his invention titled "Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient." This invention relates to a pharmaceutical composition that aims to prevent or treat inflammatory diseases or asthma by incorporating an extract or a fraction of lagerstroemia ovalifolia as an active ingredient. Additionally, it includes a health functional food and a feed additive designed to improve these conditions.
Career Highlights
Jin Hyub Paik is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on innovative research and development in the pharmaceutical sector. His dedication to improving health outcomes through scientific research is commendable.
Collaborations
Some of his notable coworkers include Kyung Seop Ahn and Sei Ryang Oh, who contribute to the collaborative efforts in their research projects.
Conclusion
Jin Hyub Paik's contributions to pharmaceutical innovations highlight the importance of research in addressing health challenges. His work continues to inspire advancements in the treatment of inflammatory diseases and asthma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
